Research CSL shares up 17% as immunoglobulin boost points to signs of recoveryBy Healthcare Propulsion StaffAugust 18, 20260 After a year of impairments, revenue downgrades and the ousting of its chief executive officer, Australian plasma and vaccine specialist…
